Synergistic Hemorrhage Control System

An innovative system integrating a stent graft device with distinct technologies such as AI, IoT, blockchain, and nanomaterials to revolutionize hemorrhage control, providing real-time feedback, predictive insights, and enhanced hemocompatibility.

The original patent addressed the pressing issue of catastrophic bleeding from large and medium-sized vessels. However, it had limitations in terms of real-time monitoring, data analysis, and secure transmission. The new inventive concept overcomes these limitations by synergistically combining the stent graft device with AI, IoT, blockchain, and nanomaterials to provide a more effective and efficient hemorrhage control system.

The Synergistic Hemorrhage Control System comprises a stent graft device configured for deployment in a blood vessel, integrated with an artificial intelligence module that analyzes blood flow data and provides real-time feedback for optimizing hemorrhage control. The system also incorporates an IoT network that transmits real-time data to a remote monitoring station, enabling healthcare providers to respond promptly. Additionally, the system utilizes a blockchain-based data management system to securely store and transmit data related to the bleeding, the stent graft device, and the treatment. Furthermore, the system features a nanomaterial-based coating applied to the stent graft device, enhancing its hemocompatibility and reducing the risk of thrombosis. A wearable device integrated with the stent graft device tracks vital signs and provides real-time feedback to healthcare providers, while a cloud-based data analytics platform analyzes the vital signs data and provides insights for optimizing hemorrhage control.

The new inventive concept introduces a synergistic combination of the stent graft device with AI, IoT, blockchain, and nanomaterials, which is not obvious from the original patent. The integration of these distinct technologies provides a novel and non-obvious solution for hemorrhage control, offering real-time feedback, predictive insights, and enhanced hemocompatibility.

Alternative embodiments of the Synergistic Hemorrhage Control System could include variations in the type of AI algorithm used, the specific IoT network architecture, or the nanomaterial composition. Additionally, the system could be adapted for use in different types of blood vessels or for treating various types of bleeding injuries.

The Synergistic Hemorrhage Control System has significant commercial potential in the medical device industry, particularly in the areas of trauma care, cardiovascular surgery, and emergency medicine. The system's ability to provide real-time feedback, predictive insights, and enhanced hemocompatibility makes it an attractive solution for hospitals, clinics, and emergency response teams.